The groundbreaking therapy of the medication represents a exciting breakthrough in the management of type 2 diabetes. Distinct from existing therapies, tirzepatide affects dual pathways – GLP-1 and GIP – leading to https://tirzepatide-peptide242528.thechapblog.com/40801480/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment